Inhibitors of DNA polymerase β:: Activity and mechanism

被引:51
作者
Gao, Zhijie [1 ]
Maloney, David J. [1 ]
Dedkova, Larisa M. [1 ]
Hecht, Sidney M. [1 ]
机构
[1] Univ Virginia, Dept Biol & Chem, Charlottesville, VA 22904 USA
关键词
polymerase inhibitor; inhibition mechanism; enzyme DNA covalent complex; antitumor agent potentiation; natural products;
D O I
10.1016/j.bmc.2008.02.071
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Bioassay-guided fractionation of extracts prepared from Couepia polyandra and Edgeworthia gardneri resulted in the isolation of the DNA polymerase beta (pol beta) inhibitors oleanolic acid (1), edgeworin (2), betulinic acid (3), and stigmasterol (4). Study of these pol b inhibitors revealed that three of them inhibited both the lyase and polymerase activities of DNA polymerase beta, while stigmasterol inhibited only the lyase activity. Further investigation indicated that the four inhibitors had substantially different effects on the DNA-pol beta binary complex that is believed to be an obligatory intermediate in the lyase reaction. It was found that the inhibitors potentiated the inhibitory action of the anticancer drug bleomycin in cultured A549 cells, without any influence on the expression of pol beta in the cells. The results of the unscheduled DNA synthesis assay support the thesis that the potentiation of bleomycin cytotoxicity by DNA pol beta inhibitors was a result of an inhibition of DNA repair synthesis. (C) 2008 Elsevier Ltd. All rights reserved.
引用
收藏
页码:4331 / 4340
页数:10
相关论文
共 62 条
[1]   A unified view of base excision repair: Lesion-dependent protein complexes regulated by post-translational modification [J].
Almeida, Karen H. ;
Sobol, Robert W. .
DNA REPAIR, 2007, 6 (06) :695-711
[2]   Targeting atypical trypanosomatid DNA topoisomerase I [J].
Balana-Fouce, Rafael ;
Redondo, Carmen M. ;
Perez-Pertejo, Yolanda ;
Diaz-Gonzalez, Rosario ;
Reguera, Rosa M. .
DRUG DISCOVERY TODAY, 2006, 11 (15-16) :733-740
[3]  
BARRA R, 1982, J NATL CANCER I, V69, P1353
[4]  
Beard WA, 1995, METHOD ENZYMOL, V262, P98
[5]   Apoptosis-modulating agents in combination with radiotherapy-current status and outlook [J].
Belka, C ;
Jendrossek, V ;
Pruschy, M ;
Vink, S ;
Verheij, M ;
Budach, W .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2004, 58 (02) :542-554
[6]   ASSOCIATION OF POLY(ADENOSINE DIPHOSPHORIBOSE) SYNTHESIS WITH DNA DAMAGE AND REPAIR IN NORMAL HUMAN-LYMPHOCYTES [J].
BERGER, NA ;
SIKORSKI, GW ;
PETZOLD, SJ ;
KUROHARA, KK .
JOURNAL OF CLINICAL INVESTIGATION, 1979, 63 (06) :1164-1171
[7]   Overexpression of DNA polymerase β in cell results in a mutator phenotype and a decreased sensitivity to anticancer drugs [J].
Canitrot, Y ;
Cazaux, C ;
Fréchet, M ;
Bouayadi, K ;
Lesca, C ;
Salles, B ;
Hoffmann, JS .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (21) :12586-12590
[8]   DNA repair: Enzymatic mechanisms and relevance to drug response [J].
Chaney, SG ;
Sancar, A .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1996, 88 (19) :1346-1360
[9]   New lupane triterpenoids from Solidago canadensis that inhibit the lyase activity of DNA polymerase β [J].
Chaturvedula, VSP ;
Zhou, BN ;
Gao, ZJ ;
Thomas, SJ ;
Hecht, SM ;
Kingston, DGI .
BIOORGANIC & MEDICINAL CHEMISTRY, 2004, 12 (23) :6271-6275
[10]   New neolignans that inhibit DNA polymerase β lyase [J].
Chaturvedula, VSP ;
Hecht, SM ;
Gao, ZJ ;
Jones, SH ;
Feng, XZ ;
Kingston, DGI .
JOURNAL OF NATURAL PRODUCTS, 2004, 67 (06) :964-967